Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53M
-
Number of holders
-
61
-
Total 13F shares, excl. options
-
16.3M
-
Shares change
-
+136K
-
Total reported value, excl. options
-
$269M
-
Value change
-
+$7.22M
-
Number of buys
-
40
-
Number of sells
-
-19
-
Price
-
$16.54
Significant Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q1 2019
71 filings reported holding CDLX - Cardlytics, Inc. - Common Stock, par value $0.0001 as of Q1 2019.
Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) has 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.3M shares
of 53M outstanding shares and own 30.69% of the company stock.
Largest 10 shareholders include FMR LLC (3.28M shares), Polaris Venture Management Co. V, L.L.C. (2.55M shares), FRONTIER CAPITAL MANAGEMENT CO LLC (1.63M shares), Canaan Partners VIII LLC (1.62M shares), JENNISON ASSOCIATES LLC (1.25M shares), CANNELL CAPITAL LLC (627K shares), Voya Investment Management LLC (521K shares), VANGUARD GROUP INC (517K shares), BlackRock Inc. (465K shares), and WELLINGTON MANAGEMENT GROUP LLP (392K shares).
This table shows the top 61 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.